Black Diamond Therapeutics
BDTX
BDTX
88 hedge funds and large institutions have $200M invested in Black Diamond Therapeutics in 2024 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.4% more ownership
Funds ownership: 73.84% → 76.24% (+2.4%)
9% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 22
Holders
88
Holding in Top 10
–
Calls
$243K
Puts
$51K
Top Buyers
| 1 | +$14.2M | |
| 2 | +$4.45M | |
| 3 | +$2.15M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$1.59M |
| 5 |
Goldman Sachs
New York
|
+$1.46M |
Top Sellers
| 1 | -$6.21M | |
| 2 | -$5.07M | |
| 3 | -$4.12M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.56M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$1.52M |